Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Short communication: HIV type 2 dynamics.

Eleonor Brandin1, Christina Broström, Elena Gille

  • 1Department of Virology, Swedish Institute for Infectious Disease Control and Microbiology and Tumorbiology Center, Karolinska Institutet, SE-171 82 Solna, Sweden.

AIDS Research and Human Retroviruses
|August 3, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modelling the role of the microbiome in antimicrobial resistance across scales.

Nature microbiology·2026
Same author

Seasonal variation in childhood acute lymphoblastic leukemia, but not in acute myeloid leukemia, or brain tumors - A Swedish population-based study.

Cancer epidemiology·2026
Same author

Haagerup Symmetry in (E_{8})_{1}?

Physical review letters·2026
Same author

Viral Simulation Reveals Overestimation Bias in Within-Host Phylodynamic Migration Rate Estimates Under Selection.

Molecular biology and evolution·2026
Same author

Long-term healthcare use of COVID-19 cases in 2020: a two-year follow-up in Stockholm, Sweden.

Annals of medicine·2025
Same author

Evaluation of a diagnostic metagenomic sequencing assay: Virus detection sensitivity and background nucleic acids in three different sample materials.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2025
Same journal

Identification of a Complex HIV-1 Circulating Recombinant Form (CRF203_cpx) Originating from Three Main Circulating Recombinant Forms in China.

AIDS research and human retroviruses·2026
Same journal

Near Full-Length Genome Characterization of a Novel Second-Generation HIV-1 CRF01_AE/CRF07_BC Recombinant Identified in an MSM Individual in Guizhou, China.

AIDS research and human retroviruses·2026
Same journal

Evolving Indications and Diagnostic Spectrum of Bone Marrow Examination in People with HIV During the Antiretroviral Therapy Era: A 6-Year Retrospective Study.

AIDS research and human retroviruses·2026
Same journal

A Conserved Natural Killer Cell Transcriptional Fingerprint in Rhesus Macaque Models of Acute Viral Infections.

AIDS research and human retroviruses·2026
Same journal

Perceived Ethical Risks of HIV Phylogenetic Research: Insights from Professional Stakeholders in Uganda.

AIDS research and human retroviruses·2026
Same journal

Genomic Characterization of Two Novel Human Immunodeficiency Virus-1 Recombinant Forms (CRF01_AE and B) in Men Who Have Sex with Men in Hebei, China.

AIDS research and human retroviruses·2026
See all related articles

Viral dynamics of human immunodeficiency virus type 2 (HIV-2) in patients on antiretroviral therapy show similar production and clearance rates to human immunodeficiency virus type 1 (HIV-1). Differences in virulence are likely due to other unidentified factors.

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • Human immunodeficiency virus type 2 (HIV-2) is generally less virulent than human immunodeficiency virus type 1 (HIV-1).
  • The underlying reasons for this difference in virulence remain largely unknown.
  • Understanding viral dynamics is crucial for explaining disease progression and severity.

Purpose of the Study:

  • To investigate the viral dynamics of HIV-2 infection in patients undergoing antiretroviral therapy (ART).
  • To compare the viral kinetics of HIV-2 with those of HIV-1.
  • To identify factors contributing to the lower virulence of HIV-2 compared to HIV-1.

Main Methods:

  • Study involved two patients with HIV-2 infection in Sweden initiating ART.
  • Viral load in plasma was measured over time.

Related Experiment Videos

  • Linear regression analysis was used to determine the decay rates (half-lives) of virus levels.
  • Preliminary estimates for different phases of viral decline were calculated.

    • Main Results:

    • Viral decline in plasma followed exponential decay during the initial 2 weeks of ART, with half-lives of 2.2 and 2.0 days.
    • These half-lives suggest the turnover rate of HIV-2 producing cells.
    • Preliminary data indicated potential differences in decline phases (1.3 and 15 days).
    • Overall viral dynamics of HIV-2 were found to be similar to HIV-1.

    Conclusions:

    • HIV-1 and HIV-2 exhibit comparable in vivo production and clearance rates.
    • The observed differences in virulence and disease course between HIV-1 and HIV-2 are not explained by their viral dynamics alone.
    • Other unidentified host or viral factors likely account for the distinct clinical outcomes.